Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 1993 Apr;152(4):372-4.
doi: 10.1007/BF01956757.

Intravenous immunoglobulin in two children with Guillain-Barré syndrome

L D Notarangelo  1 , M Duse, S Tiberti, B Guarneri, A Brunori, A Negrini, A G Ugazio
Affiliations
Case Reports

Intravenous immunoglobulin in two children with Guillain-Barré syndrome

L D Notarangelo et al. Eur J Pediatr. 1993 Apr.

Abstract

Two children with Guillain-Barrè syndrome were successfully treated with high-dose intravenous immunoglobulin (IVIG) and no relapses occurred over a 1 year follow up. No side-effects were observed. These data provide further evidence that IVIG may be safely and effectively employed in children with Guillain-Barrè syndrome.

PubMed Disclaimer

References

    1. Lancet. 1984 Oct 6;2(8406):765-8 - PubMed
    1. Rev Neurol (Paris). 1989;145(10):731-2 - PubMed
    1. Neurology. 1988 Oct;38(10):1639-41 - PubMed
    1. Ann Neurol. 1986 Jun;19(6):573-7 - PubMed
    1. J Pediatr. 1990 Jan;116(1):141-4 - PubMed

Publication types

Substances